As shown in Figure 2, p53 upregulated the antitumor genes NDRG1 and BTG2, consistent with previous studies [31,33,45], but downregulated MALT1 expression in human prostate carcinoma cells, which may lead to an antitumor effect. The gene discussed is BTG2; the disease is prostate carcinoma.